CALML3 and systemic sclerosis: Double immunofluorescence staining of Chi3L1 and CALML3, another marker of Chi3L1hi basal cells, validated the enrichment of Chi3L1hi basal cells in the skin of patients with SSc, as indicated by the transcriptomic data (Figure 1J; Figure S3, Supporting Information).